Coronavirus — FDA Approves Emergency Use of Regeneron Cocktail

  • The use of the medicine was authorized to be used in the early stages of the viral disease, even before showing symptoms.
  • President Trump was among the first to take publicly this remedy.
  • Vaccines seem to still take precedence of the FDA

The United States Food Administration (FDA) has issued an emergency use authorization for Regeneron’s antibody cocktail to treat people who are in high-risk categories, those over 65, and younger people with medical conditions. This product was used on President Trump when he entered Wallter Reed Medical Center.

The Food and Drug Administration (FDA or USFDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments.

The use of the medicine was authorized to be used in the early stages of the viral disease, even before showing symptoms, but after having been tested positive. This is the first emergency authorization of the FDA for treatment of people in the early stages of Coronavirus.

After the outbreak of Coronavirus in March, a doctor in the Upstate New York town of Monroe, Dr. Vladimir Zelenko, experimented with early stage treatment of Coronavirus in his clinic using a combination of Hydrochloroquine Sulphate, Zinc Sulphate, and Azithromycin.  He claimed exceptional success with his patients and notified President Trump about the possibility of using this combination to save lives of Americans. 

President Trump received his recommendation from Dr. Zelenko, which requested emergency authorization for treatment from the FDA. The FDA, at this time, gave authorization for the use of Hydrochloroquine in hospitals for patients who had already developed symptoms needing hospitalization.

The idea of Dr. Zelenko was to use this treatment in the early stages of the infection and not in moderate or serious cases. Later, after experimenting with Hydrochloroquine in hospital use, the authorization was removed by the FDA as not effective or possibly being dangerous.

Until now, the FDA did not consider authorization of any medical solutions for patients in the early stages of the virus. Now, after President Trump has lost the election, the FDA has approved Rengeron’s antibody cocktail remedy for high risk Coronavirus patients and patients that have mild to moderate symptoms.

The treatment works best when used early on after diagnosis. The cocktail is being shipped nationwide and works by mimicking an immune system’s response to an infection. It has already reduced COVID-19 related hospitalizations and emergency room visits for people across the country.

The FDA now is beginning to act fast to respond to the urgent needs for patients instead of waiting for the disease to penetrate the lungs of the patients. Doctors in outpatient clinics now have a tool to prevent hospitalization and to save lives. The government will establish who will get the initial supply, which is enough for 300,000 people, which will surely be insufficient.

The CEO of Rengeron is encouraging federal and state governments to distribute the drug fairly. Further testing will be made to satisfy all the qualifications of the FDA for a complete approval, not only for emergencies.

Hydroxychloroquine (HCQ), sold under the brand name Plaquenil among others, is a medication used for the prevention and treatment of certain types of malaria. Other uses include treatment of rheumatoid arthritis, lupus, and porphyria cutanea tarda.

Drugs have been recommended by doctors to treat Coronavirus in the early stages, but in the past, the FDA refused to consider these recommendations like hydroxychloroquine, Remdesvir, and other anti-viral drugs. There were front line doctors who were suspended for making decisions to use these drugs without FDA approval.

President Trump attempted to initiate the idea of treating COVID-19 in the early stages with Hydrochlorquine when he himself took the drug for prophylactic treatment to show that it was not dangerous. When he went into Walter Reed Medical Center, he was treated with this cocktail and Remdesvir, even before he developed symptoms.

Many people feel that the FDA did not act fast enough for Americans in high-risk categories, which could have prevented deaths. Dr. Zelenko and his recommendation was not given the proper attention by the FDA. They did not even make experiments to do research on the use of anti-virals on Coronavirus patients in the early stages.

Now that President Trump has lost the election, and vaccines have been developed, which are for sure important, the FDA has removed its sanctions on treatment of Coronavirus patients in the early stages with this cocktail.

Only $1/click

Submit Your Ad Here

David Wexelman

Author of 5 books on the internet on topics of Jewish mysticism, managing two websites.

2 thoughts to “Coronavirus — FDA Approves Emergency Use of Regeneron Cocktail”

  1. It is so sad that the Pharmaceutical Industry would use their power to deprive patients of any helpful treatment, when one is needed and there is no better alternative. Yet we HAVE seen them use their power to go after Trump, then delay the vaccine release until after the election.
    I am glad to see that Regeneron has been approved for at least limited distribution. Hopefully they will get enough of the drug available soon for all who need it.
    We all know politicians will be politicians. Still it is a surprise to see the evil swamp creatures, lobbiest fall to new lows when Americans were still fighting the virus on their own. The vaccines should have been available a month ago. These companies put their thumb on the scale to defeat Trump and at the expense of American lives!

Leave a Reply